Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 43
Filtrar
1.
Eur J Med Chem ; 265: 116125, 2024 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-38185055

RESUMO

Peroxisome proliferator-activated receptors (PPARs) play a major role in regulating inflammatory processes, and dual or pan-PPAR agonists with PPARγ partial activation have been recognised to be useful to manage both metabolic syndrome and metabolic dysfunction-associated fatty liver disease (MAFLD). Previous works have demonstrated the capacity of 2-prenylated benzopyrans as PPAR ligands. Herein, we have replaced the isoprenoid bond by hydrazone, a highly attractive functional group in medicinal chemistry. In an attempt to discover novel and safety PPAR activators, we efficiently prepared benzopyran hydrazone/hydrazine derivatives containing benzothiazole (series 1) or 5-chloro-3-(trifluoromethyl)-2-pyridine moiety (series 2) with a 3- or 7-carbon side chain at the 2-position of the benzopyran nucleus. Benzopyran hydrazones 4 and 5 showed dual hPPARα/γ agonism, while hydrazone 14 exerted dual hPPARα/δ agonism. These three hydrazones greatly attenuated inflammatory markers such as IL-6 and MCP-1 on the THP-1 macrophages via NF-κB activation. Therefore, we have discovered novel hits (4, 5 and 14), containing a hydrazone framework with dual PPARα/γ or PPARα/δ partial agonism, depending on the length of the side chain. Benzopyran hydrazones emerge as potential lead compounds which could be useful for treating metabolic diseases.


Assuntos
Benzopiranos , PPAR alfa , Humanos , PPAR alfa/agonistas , Benzopiranos/química , Hidrazonas/farmacologia , Hipoglicemiantes , PPAR gama/agonistas , Anti-Inflamatórios
2.
J Migr Health ; 8: 100205, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-38047139

RESUMO

Background: Migrants in host countries are at risk for the development of mental health conditions. The two aims of the study were to describe routine diagnoses of mental disorders among migrant patients at primary healthcare level and the associated risk factors, and to test the utility of an innovative migrant mental health assessment by evaluating whether the health professionals followed the recommendations proposed by the clinical decision support system (CDSS) tool. Methods: A cross-sectional study was carried out in eight primary care centres (PCCs) in four non-randomly selected health regions of Catalonia, Spain from March to December 2018. Routine health data and mental health diagnoses based on the International Classification of Diseases (10th edition), including mental, behavioural and neuro developmental disorders (F01-F99), symptoms and signs involving emotional state (R45), and sleep disorders (G47), were extracted from the electronic health records. The proportion of mental health conditions was estimated and logistic regression models were used to assess any possible association with mental health disorders. The utility of the mental health assessment was assessed with the proportion of questionnaires performed by health professionals for migrants fulfilling the mental health screening criterion (country of origin with an active conflict in 2017) and the diagnoses given to the screened patients. Results: Of 14,130 migrants that visited any of the PCCs during the study period, 7,358 (52.1 %) were women with a median age of 38.0 years-old. There were 520/14,130 (3.7 %) migrant patients diagnosed with a mental disorder, being more frequent among women (342/7,358; 4.7 %, p-value < 0.001), migrants from Latin-America (177/3,483; 5.1 %, p < 0.001) and those who recently arrived in Spain (170/3,672; 4.6 %, p < 0.001). A lower proportion of mental disorders were reported in migrants coming from conflicted countries in 2017 (116/3,669, 3.2 %, p = 0.053).Out of the 547 mental health diagnoses reported in 520 patients, 69/14,130 (0.5 %) were mood disorders, 346/14,130 (2.5 %) anxiety disorders and 127/14,130 (0.9 %) sleeping disorders. Mood disorders were more common in migrants from Eastern Europe (25/2,971; 0.8 %, p < 0.001) and anxiety disorders in migrants from Latin-America (126/3,483; 3.6 %, p < 0.001), while both type of disorders were more often reported in women (p < 0.001).In the adjusted model, women (aOR: 1.5, [95 % CI 1.2-1.8, p < 0.001]), migrants with more than one visit to the health center during the study period (aOR: 4.4, [95 %CI 2.8-6.8, p < 0.001]) and who presented an infectious disease (aOR: 2.1, [95 %CI 1.5-3.1, p < 0.001]) had higher odds of having a mental disorder.Lastly, out of the 1,840 migrants coming from a conflicted country in 2017 who were attended in centres where the CDSS tool was implemented, 29 (1.6 %) had a mental health assessment performed and the tool correctly identified one individual. Conclusions: Mental health is a condition that may be overlooked in migrants at primary healthcare. Interventions at this level of care must be reinforced and adapted to the needs and circumstances of migrants to ensure equity in health services.

3.
RSC Med Chem ; 14(11): 2327-2341, 2023 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-38020071

RESUMO

Synthesis of three series of 2-aminopropyl derivatives containing a benzopyran nucleus was performed to evaluate their performance against triple-negative breast cancer cell lines (MDA-MB-231 and MDA-MB-436) and normal breast epithelial cells (MCF10A). For the three series, the cytotoxic activity was as follows: N-methylated derivatives (tertiary amines) 5b, 6b, and 7b > secondary amine benzopyrans 5, 6, and 7 > quaternary amine salts 5c, 6c, and 7c > free phenolic derivatives 5a, 6a, and 7a. The structure-activity relationship showed the importance of the presence of an amine group and a p-fluorobenzyloxy substituent in the chromanol ring (IC50 values from 1.5 µM to 58.4 µM). In addition, 5a, 5b, 6a, and 7b displayed slight selectivity towards tumor cells. Compounds 5, 5a, 5b, 6, 6a, 6c, 7, and 7b showed apoptotic/necrotic effects due to, at least in part, an increase in reactive oxygen species generation, whereas 5b, 5c, 6b, 7a, and 7c caused cell cycle arrest in the G1 phase. Further cell-based mechanistic studies revealed that 5a, 6a, and 7b, which were the most promising compounds, downregulated the expression of Bcl-2, while 5b downregulated the expression of cyclins CCND1 and CCND2. Therefore, 2-aminopropyl benzopyran derivatives emerge as new hits and potential leads for developing useful agents against breast cancer.

4.
Pharmacol Res ; 187: 106638, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-36586645

RESUMO

BACKGROUND AND PURPOSE: Selective peroxisome proliferator-activated receptors (PPARs) are widely used to treat metabolic complications; however, the limited effect of PPARα agonists on glucose metabolism and the adverse effects associated with selective PPARγ activators have stimulated the development of novel pan-PPAR agonists to treat metabolic disorders. Here, we synthesized a new prenylated benzopyran (BP-2) and evaluated its PPAR-activating properties, anti-inflammatory effects and impact on metabolic derangements. EXPERIMENTAL APPROACH: BP-2 was used in transactivation assays to evaluate its agonism to PPARα, PPARß/δ and PPARγ. A parallel-plate flow chamber was employed to investigate its effect on TNFα-induced leukocyte-endothelium interactions. Flow cytometry and immunofluorescence were used to determine its effects on the expression of endothelial cell adhesion molecules (CAMs) and chemokines and p38-MAPK/NF-κB activation. PPARs/RXRα interactions were determined using a gene silencing approach. Analysis of its impact on metabolic abnormalities and inflammation was performed in ob/ob mice. KEY RESULTS: BP-2 displayed strong PPARα activity, with moderate and weak activity against PPARß/δ and PPARγ, respectively. In vitro, BP-2 reduced TNFα-induced endothelial ICAM-1, VCAM-1 and fractalkine/CX3CL1 expression, suppressed mononuclear cell arrest via PPARß/δ-RXRα interactions and decreased p38-MAPK/NF-κB activation. In vivo, BP-2 improved the circulating levels of glucose and triglycerides in ob/ob mice, suppressed T-lymphocyte/macrophage infiltration and proinflammatory markers in the liver and white adipose tissue, but increased the expression of the M2-like macrophage marker CD206. CONCLUSION AND IMPLICATIONS: BP-2 emerges as a novel pan-PPAR lead candidate to normalize glycemia/triglyceridemia and minimize inflammation in metabolic disorders, likely preventing the development of further cardiovascular complications.


Assuntos
Doenças Metabólicas , PPAR delta , PPAR beta , Camundongos , Animais , PPAR gama/metabolismo , PPAR alfa/metabolismo , PPAR beta/metabolismo , Fator de Necrose Tumoral alfa , Benzopiranos , NF-kappa B , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios/uso terapêutico , Inflamação/tratamento farmacológico
5.
Epidemiologia (Basel) ; 3(2): 179-190, 2022 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-36417250

RESUMO

During the period from March 2020 to January 2021, we performed an analysis of incidence, mortality, and risk factors of COVID-19 in nursing homes (NHs) in two health departments (HDs) of Castellon (Spain) 2021 through epidemiological surveillance and an ecological design. Laboratory-confirmed COVID-19 cases, cumulative incidence rate (CIR), and mortality rate (MR) of 27 NHs were collected. Information of residents, staff, and facilities was obtained by questionnaire. Multilevel Poisson regression models were applied. All NHs in the HDs participated with 2229 residents (median: 83 years old, 67.3% women) and 1666 staff. Among residents, 815 cases (CIR: 34.8 per 100) and 202 deaths (MR: 8.7 per 100, case fatality 21.0%) were reported and, among staff, 296 cases (CIR: 19.2 per 100) without deaths. Residents' CIR and MR increased with staff CIR, age of the building, residents/staff ratios, occupancy rate, and crowding index; CIR increased with private NH ownership, large NH size, large urban area, and the percentage of women residents; and MR was associated with residents' severe disabilities. In conclusion, several risk factors of COVID-19 incidence and mortality can be prevented by improving infection and quality controls, ameliorating residents/staff ratios, improving structural facilities, and increasing NH public ownership to avoid new outbreaks.

6.
J Travel Med ; 29(7)2022 11 04.
Artigo em Inglês | MEDLINE | ID: mdl-34230959

RESUMO

BACKGROUND: There are major shortfalls in the identification and screening of at-risk migrant groups. This study aims to evaluate the effectiveness of a new digital tool (IS-MiHealth) integrated into the electronic patient record system of primary care centres in detecting prevalent migrant infections. IS-MiHealth provides targeted recommendations to health professionals for screening multiple infections, including human immunodeficiency virus (HIV), hepatitis B and C, active tuberculosis (TB), Chagas disease, strongyloidiasis and schistosomiasis, based on patient characteristics (including variables of country of origin, age and sex). METHODS: A pragmatic pilot cluster-randomized-controlled trial was deployed from March to December 2018. Eight primary care centres in Catalonia, Spain, were randomly allocated 1:1 to use of the digital tool for screening, or to routine care. The primary outcome was the monthly diagnostic yield of all aggregated infections. Intervention and control sites were compared before and after implementation with respect to their monthly diagnostic yield using regression models. This study is registered on international standard randomised controlled trial number (ISRCTN) (ISRCTN14795012). RESULTS: A total of 15 780 migrants registered across the eight centres had at least one visit during the intervention period (March-December 2018), of which 14 598 (92.51%) fulfilled the criteria to be screened for at least one infection. There were 210 (2.57%) individuals from the intervention group with new diagnoses compared with 113 (1.49%) from the control group [odds ratio: 2.08, 95% confidence interval (CI) 1.63-2.64, P < 0.001]. The intervention centres raised their overall monthly diagnosis rate to 5.80 (95% CI 1.23-10.38, P = 0.013) extra diagnoses compared with the control centres. This monthly increase in diagnosis in intervention centres was also observed if we consider all cases together of HIV, hepatitis B and C, and active TB cases [2.72 (95% CI 0.43-5.00); P = 0.02] and was observed as well for the parasitic infections' group (Chagas disease, strongyloidiasis and schistosomiasis) 2.58 (95% CI 1.60-3.57; P < 0.001). CONCLUSIONS: The IS-MiHealth increased screening rate and diagnostic yield for key infections in migrants in a population-based primary care setting. Further testing and development of this new tool is warranted in larger trials and in other countries.


Assuntos
Doença de Chagas , Infecções por HIV , Hepatite B , Estrongiloidíase , Migrantes , Tuberculose , Humanos , Infecções por HIV/diagnóstico , Infecções por HIV/epidemiologia , Atenção Primária à Saúde/métodos , Doença de Chagas/diagnóstico , Doença de Chagas/epidemiologia
7.
Bioorg Med Chem ; 53: 116532, 2022 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-34863066

RESUMO

2-Prenylated benzopyrans represent a class of natural and synthetic compounds showing a wide range of significant activities. Polycerasoidol is a natural prenylated benzopyran isolated from the stem bark of Polyalthia cerasoides (Annonaceae) that exhibits dual PPARα/γ agonism and an anti-inflammatory effect by inhibiting mononuclear leukocyte adhesion to the dysfunctional endothelium. Herein, we report the synthesis of three new series of prenylated benzopyrans containing one (series 1), two (series 2, "polycerasoidol" analogs) and three (series 3, "trans-δ-tocotrienolic acid" analogs) isoprenoid units in the hydrocarbon side chain at the 2-position of the chroman-6-ol (6-hydroxy-dihydrobenzopyran) scaffold. Isoprenoid moieties were introduced through a Grignard reaction sequence, followed by Johnson-Claisen rearrangement and subsequent Wittig olefination. hPPAR transactivation activity and the structure activity relationships (SAR) of eleven novel synthesized 2-prenylated benzopyrans were explored. PPAR transactivation activity demonstrated that the seven-carbon side chain analogs (series 1) displayed selectivity for hPPARα, while the nine-carbon side chain analogs (polycerasoidol analogs, series 2) did so for hPPARγ. The side chain elongation to 11 or 13 carbons (series 3) resulted in weak dual PPARα/γ activation. Therefore, 2-prenylated benzopyrans of seven- and nine-carbon side chain (polycerasoidol analogs) are good lead compounds for developing useful candidates to prevent cardiovascular diseases associated with metabolic disorders.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Benzopiranos/farmacologia , PPAR alfa/agonistas , PPAR gama/agonistas , Vitamina E/análogos & derivados , Anti-Inflamatórios não Esteroides/síntese química , Anti-Inflamatórios não Esteroides/química , Benzopiranos/síntese química , Benzopiranos/química , Relação Dose-Resposta a Droga , Humanos , Estrutura Molecular , Relação Estrutura-Atividade , Vitamina E/síntese química , Vitamina E/química , Vitamina E/farmacologia
8.
ACS Med Chem Lett ; 12(11): 1783-1786, 2021 Nov 11.
Artigo em Inglês | MEDLINE | ID: mdl-34795868

RESUMO

We have synthesized series of 2-prenylated benzopyrans as analogues of the natural polycerasoidol, a dual PPARα/γ agonist with anti-inflammatory effects. The prenylated side chain consists of five or nine carbons with an α-alkoxy-α,ß-unsaturated ester moiety. Prenylation was introduced via the Grignard reaction, followed by Johnson-Claisen rearrangement, and the α-alkoxy-α,ß-unsaturated ester moiety was introduced by the Horner-Wadsworth-Emmons reaction. Synthetic derivatives showed high efficacy to activate both hPPARα and hPPARγ as dual PPARα/γ agonists. These prenylated benzopyrans emerge as lead compounds potentially useful for preventing cardiometabolic diseases.

9.
Orinoquia ; 25(1): 95-101, Jan.-June 2021.
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1351174

RESUMO

Resumen La gestión de riesgos laborales se conceptualiza como la administración de los Factores de Riesgos asociados a las labores mediante su identificación, análisis, valoración e intervención a través de acciones, actividades y programas que permitan mitigar y/o controlar los riesgos, contribuyendo con ambientes confortables y seguros. Sin embargo, cuando se habla del Teletrabajo móvil, la normatividad actual colombiana, no evidencia la manera en que se deban identificar los factores de riesgo y/o peligros, ni cómo valorar los riesgos propiamente dichos o las estrategias de intervención para evitar la ocurrencia de enfermedades y/o accidentes de trabajo. Además, la gestión de riesgos se dificulta no solo porque no existen metodologías para la diversidad de condiciones y lugares de trabajo sino porque las existentes no contemplan esta modalidad de contratación, ya que el teletrabajador móvil no tiene un lugar fijo para trabajar. Esto conlleva a re-evaluar diferentes estrategias que permitan identificar peligros, valorar riesgos y determinar controles, dentro del ejercicio de implementación del Sistema de Gestión de Seguridad y Salud en el Trabajo en Colombia SG-SST* (Ministerio de Trabajo 2015). Es así como, el grupo de Investigación: Sociedad, Estrategia y Seguridad de la Universidad Militar Nueva Granada, INV-EES-2605, elaboró este artículo con el fin de reflexionar sobre la importancia de la implementación del SG-SST en las empresas que apliquen la modalidad de Teletrabajo Móvil en Colombia. La técnica utilizada para la elaboración del presente artículo incluyó el trabajo de campo realizado durante el desarrollo de la investigación, el cual comprendió visitas a teletrabajadores, como estrategia metodológica para la identificación de los peligros, evaluación y valoración de los riesgos y así establecer un diagnóstico en Riesgos Laborales en teletrabajadores y sus empresas en la Ciudad de Bogotá. Adicionalmente, abarcó la búsqueda sistemática de información bibliográfica relacionada con esta modalidad de trabajo a nivel Nacional e internacional.


Abstract Occupational risk management is conceptualized as the management of Risk Factors associated with work through their identification, analysis, assessment and intervention through actions, activities and programs that allow mitigating and / or controlling risks, contributing to comfortable environments and insurance. However, when talking about mobile teleworking, the current Colombian regulations do not show the way in which risk factors and / or dangers should be identified, nor how to assess the risks themselves or the intervention strategies to avoid the occurrence of work illnesses and / or accidents. In addition, risk management is difficult not only because there are no methodologies for the diversity of conditions and workplaces but also because the existing ones do not contemplate this type of hiring, since the mobile teleworker does not have a fixed place to work. This leads to re-evaluating different strategies that allow identifying hazards, assessing risks and determining controls, within the exercise of implementation of the Management System for Safety and Health at Work in Colombia SG-SST * (Ministry of Labor 2015). Thus, the Research group: Society, Strategy and Security of the Nueva Granada Military University, INV-EES-2605, prepared this article in order to reflect on the importance of the implementation of the SG-SST in the companies that apply the modality of Mobile Teleworking in Colombia. The technique used for the preparation of this article included the field work carried out during the development of the research, which included visits to teleworkers, as a methodological strategy for the identification of hazards, evaluation and assessment of risks and thus establish a diagnosis in Occupational Risks in teleworkers and their companies in the City of Bogotá. Additionally, it covered the systematic search for bibliographic information related to this type of work at the national and international level.


Resumo A gestão do risco ocupacional é conceituada como a gestão dos Fatores de Risco associados ao trabalho através da sua identificação, análise, avaliação e intervenção através de ações, atividades e programas que permitem mitigar e / ou controlar os riscos, contribuindo para ambientes e seguros confortáveis. No entanto, quando se trata de teletrabalho móvel, os atuais regulamentos colombianos não mostram a forma como os fatores de risco e / ou perigos devem ser identificados, nem como avaliar os próprios riscos ou as estratégias de intervenção para evitar a ocorrência de doenças do trabalho e / ou acidentes. Além disso, a gestão de riscos é difícil não só porque não existem metodologias para a diversidade de condições e locais de trabalho, mas também porque as existentes não contemplam este tipo de contratação, uma vez que o teletrabalhador móvel não dispõe de local fixo para trabalhar. Isto leva a reavaliar diferentes estratégias que permitem identificar perigos, avaliar riscos e determinar controles, dentro do exercício de implementação do Sistema de Gestão de Segurança e Saúde no Trabalho na Colômbia SG-SST * (Ministério do Trabalho 2015). Assim, o Grupo de Pesquisa: Sociedade, Estratégia e Segurança da Universidade Militar Nueva Granada, INV-EES-2605, elaborou este artigo com o objetivo de refletir sobre a importância da implementação do SG-SST nas empresas que aplicam a modalidade de Teletrabalho móvel na Colômbia. A técnica utilizada para a elaboração deste artigo compreendeu o trabalho de campo realizado durante o desenvolvimento da pesquisa, que incluiu visitas a teletrabalhadores, como estratégia metodológica para a identificação de perigos, avaliação e avaliação de riscos e assim estabelecer um diagnóstico em Ocupacional. Riscos em teletrabalhadores e suas empresas na cidade de Bogotá. Além disso, abrangeu a busca sistemática de informações bibliográficas relacionadas a esse tipo de trabalho em nível nacional e internacional.

11.
J Nat Prod ; 83(1): 127-133, 2020 01 24.
Artigo em Inglês | MEDLINE | ID: mdl-31933369

RESUMO

Certain D2-like dopamine receptor (DR) agonists are useful therapeutically as antiparkinsonian drugs, whereas D2-like DR antagonists or partial agonists are proven effective as antipsychotics. Two isoquinoline derivatives, 1-(2'-bromobenzyl)-6,7-dihydroxy-N-methyl-tetrahydroisoquinoline (Br-BTHIQ, 1) and 1,2-demethyl-nuciferine (aporphine, 2), were herein synthesized, and their dopaminergic affinity in cloned human D2R, D3R, and D4R subtypes and their behavior as agonists/antagonists were evaluated. They showed affinity values (Ki) for hD2, hD3, and hD4 DR within the nanomolar range. The trends in affinity were hD4R ≫ hD3R > hD2R for Br-BTHIQ (1) and hD2R > hD4R > hD3R for 1,2-demethyl-nuciferine (2). The functional assays of cyclic adenosine monophosphate signaling at human D2R showed a partial agonist effect for Br-BTHIQ (1) and full agonist behavior for aporphine (2), with half maximal effective concentration values of 2.95 and 10.2 µM, respectively. Therefore, both isoquinolines 1 and 2 have emerged as lead molecules for the synthesis of new therapeutic drugs that ultimately may be useful to prevent schizophrenia and Parkinson's disease, respectively.


Assuntos
Aporfinas/química , AMP Cíclico/química , Agonistas de Dopamina/química , Tetra-Hidroisoquinolinas/farmacologia , Animais , Aporfinas/farmacologia , Humanos , Isoquinolinas/química , Estrutura Molecular , Tetra-Hidroisoquinolinas/química
12.
Nanomaterials (Basel) ; 9(12)2019 Nov 24.
Artigo em Inglês | MEDLINE | ID: mdl-31771274

RESUMO

Thousands of nanomaterials (NMs)-containing products are currently under development or incorporated in the consumer market, despite our very limited understanding of their genotoxic potential. Taking into account that the toxicity and genotoxicity of NMs strongly depend on their physicochemical characteristics, many variables must be considered in the safety evaluation of each given NM. In this scenario, the challenge is to establish high-throughput methodologies able to generate rapid and robust genotoxicity data that can be used to critically assess and/or predict the biological effects associated with those NMs being under development or already present in the market. In this study, we have evaluated the advantages of using a flow cytometry-based approach testing micronucleus (MNs) induction (FCMN assay). In the frame of the EU NANoREG project, we have tested six different NMs-namely NM100 and NM101 (TiO2NPs), NM110 (ZnONPs), NM212 (CeO2NPs), NM300K (AgNPs) and NM401 (multi-walled carbon nanotubes (MWCNTs)). The obtained results confirm the ability of AgNPs and MWCNTs to induce MN in the human bronchial epithelial BEAS-2B cell line, whereas the other tested NMs retrieved non-significant increases in the MN frequency. Based on the alignment of the results with the data reported in the literature and the performance of the FCMN assay, we strongly recommend this assay as a reference method to systematically evaluate the potential genotoxicity of NMs.

13.
Bioorg Med Chem ; 27(24): 115162, 2019 12 15.
Artigo em Inglês | MEDLINE | ID: mdl-31703893

RESUMO

We describe the synthesis of 26 compounds, small polycerasoidol analogs, that are Lipinski's rule-of-five compliant. In order to confirm key structural features to activate PPARα and/or PPARγ, we have adopted structural modifications in the following parts: (i) the benzopyran core (hydrophobic nucleus) by benzopyran-4-one, dihydrobenzopyran or benzopyran-4-ol; (ii) the side chain at 2-position by shortening to C3, C4 and C5-carbons versus C-9-carbons of polycerasoidol; (iii) the carboxylic group (polar head) by oxygenated groups (hydroxyl, acetoxy, epoxide, ester, aldehyde) or non-oxygenated motifs (allyl and alkyl). Benzopyran-4-ones 6, 12, 13 and 17 as well as dihydrobenzopyrans 22, 24 and 25 were able to activate hPPARα, whereas benzopyran-4-one (7) with C5-carbons in the side chain exhibited hPPARγ agonism. According to our previous docking studies, SAR confirm that the hydrophobic nucleus (benzopyran-4-one or dihydrobenzopyran) is essential to activate PPARα and/or PPARγ, and the flexible linker (side alkyl chain) should containg at least C5-carbon atoms to activate PPARγ. By contrast, the polar head ("carboxylic group") tolerated several oxygenated groups but also non-oxygenated motifs. Taking into account these key structural features, small polycerasoidol analogs might provide potential active molecules useful in the treatment of dyslipidemia and/or type 2 diabetes.


Assuntos
Benzopiranos/síntese química , Benzopiranos/farmacologia , PPAR alfa/agonistas , PPAR gama/agonistas , Benzopiranos/química , Descoberta de Drogas , Estrutura Molecular , Relação Estrutura-Atividade
14.
Nanomaterials (Basel) ; 9(10)2019 Sep 27.
Artigo em Inglês | MEDLINE | ID: mdl-31569740

RESUMO

The interesting physicochemical characteristics of nanomaterials (NMs) has brought about their increasing use and, consequently, their increasing presence in the environment. As emergent contaminants, there is an urgent need for new data about their potential side-effects on human health. Among their potential effects, the potential for DNA damage is of paramount relevance. Thus, in the context of the EU project NANoREG, the establishment of common robust protocols for detecting genotoxicity of NMs became an important aim. One of the developed protocols refers to the use of the comet assay, as a tool to detect the induction of DNA strand breaks. In this study, eight different NMs-TiO2NP (2), SiO2NP (2), ZnONP, CeO2NP, AgNP, and multi-walled carbon nanotubes (MWCNT)-were tested using two different human lung epithelial cell lines (A549 and BEAS-2B). The comet assay was carried out with and without the use of the formamidopyrimidine glycosylase (FPG) enzyme to detect the induction of oxidatively damaged DNA bases. As a high throughput approach, we have used GelBond films (GBF) instead of glass slides, allowing the fitting of 48 microgels on the same GBF. The results confirmed the suitability of the comet assay as a powerful tool to detect the genotoxic potential of NMs. Specifically, our results indicate that most of the selected nanomaterials showed mild to significant genotoxic effects, at least in the A549 cell line, reflecting the relevance of the cell line used to determine the genotoxic ability of a defined NM.

15.
Med Clin (Barc) ; 153(3): 93-99, 2019 08 02.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-30857796

RESUMO

BACKGROUND AND OBJECTIVE: The objective of the study was to evaluate the effects of a multidisciplinary intervention on the outcomes of polypathological patients (PP). METHODS: A multicenter quasi-experimental pre-post study with a 12-month follow up was performed. In-hospital, at discharge and outpatient clinics patients who met criteria of PP between March 2012 and October 2013 were included. The multidisciplinary approach was defined by 11 interventions performed by general practitioners, internal medicine physicians, team care nurses and hospital pharmacists. The primary outcome was reduction in the number of hospital admissions and days of hospitalization. Secondary outcomes included mortality and the effects of 11 interventions on mortality. RESULTS: 420 patients were included. Mean patient age was 77.3 (SD: 8.90) and average number of PP defining categories was 2.99 (SD: 1.00). Number of hospital admissions and days of hospitalization decreased significantly after intervention: 1.52 (SD: 1.35) versus 0.82 (SD: 1.29), p<0.001, and 13.77 (SD: 15.20) versus 7.21 (SD: 12.90), p<0.001 respectively. 12-month mortality was 37.7%. PP who failed to receive a structured medical visit from the internal medicine physician and educational workshops from the team care nurses had a higher risk of exitus in the next 12 months, HR: 1.68; 95% CI: 1.15-2.46, p=0.007 and HR: 2.86; 95% CI: 1.92-4.27, p<0.001, respectively. CONCLUSIONS: This multidisciplinary intervention reduced the risk of PP hospital admission and days of hospitalization. Educational workshop programs for PP and their caregivers and structured IM medical visits were associated with improvements of survival.


Assuntos
Doença Crônica/terapia , Prestação Integrada de Cuidados de Saúde , Multimorbidade , Equipe de Assistência ao Paciente , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Doença Crônica/mortalidade , Feminino , Humanos , Tempo de Internação/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Admissão do Paciente/estatística & dados numéricos , Análise de Sobrevida , Resultado do Tratamento , Adulto Jovem
16.
Arch Pharm (Weinheim) ; 352(3): e1800298, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30648282

RESUMO

The synthesis of inhibitors of SphK2 with novel structural scaffolds is reported. These compounds were designed from a molecular modeling study, in which the molecular interactions stabilizing the different complexes were taken into account. Particularly interesting is that 7-bromo-2-(2-phenylethyl)-2,3,4,5-tetrahydro-1,4-epoxynaphtho[1,2-b]azepine, which is a selective inhibitor of SphK2, does not exert any cytotoxic effects and has a potent anti-inflammatory effect. It was found to inhibit mononuclear cell adhesion to the dysfunctional endothelium with minimal impact on neutrophil-endothelial cell interactions. The information obtained from our theoretical and experimental study can be useful in the search for inhibitors of SphK2 that play a prominent role in different diseases, especially in inflammatory and cardiovascular disorders.


Assuntos
Anti-Inflamatórios/síntese química , Azepinas/síntese química , Inibidores Enzimáticos/síntese química , Compostos de Epóxi/síntese química , Fosfotransferases (Aceptor do Grupo Álcool)/antagonistas & inibidores , Anti-Inflamatórios/química , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios/toxicidade , Azepinas/química , Azepinas/farmacologia , Adesão Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Desenho de Fármacos , Endotélio Vascular/efeitos dos fármacos , Endotélio Vascular/imunologia , Inibidores Enzimáticos/química , Inibidores Enzimáticos/farmacologia , Inibidores Enzimáticos/toxicidade , Compostos de Epóxi/química , Compostos de Epóxi/farmacologia , Células Endoteliais da Veia Umbilical Humana , Humanos , Simulação de Acoplamento Molecular , Neutrófilos/efeitos dos fármacos , Neutrófilos/imunologia , Ligação Proteica , Relação Estrutura-Atividade
17.
Aten Primaria ; 51(2): 71-79, 2019 02.
Artigo em Espanhol | MEDLINE | ID: mdl-29157932

RESUMO

OBJECTIVE: To determine the prevalence and profiles of people with advanced chronic diseases in Primary Care and to analyse the elements related to their mortality in order to orient strategies for improvement in this level of care. DESIGN: An observational, analytical and prospective study during 3 years conducted on a cohort of patients with palliative needs. LOCATION: Three Primary Care teams of Osona (Catalonia). PARTICIPANTS: A total of 251 people identified as advanced patients using a systematic population-based strategy that included the NECPAL tool. MAIN MEASUREMENTS: Basic demographic and clinical profile (age, gender, type of residence, health stratification level and main disease); date, place, and cause of eventual deaths. RESULTS: 1% of the adult Primary Care population suffer from advanced diseases, of which 56.6% are women, and with a median age of 85 years. Dementia or advanced frailty is observed in 49.3%, and only 13.7% have cancer. Just under one-quarter (24.3%) live in nursing homes. The accumulated mortality at 3 years is 62.1%, with a median survival of 23 months. Factors significantly associated with the likelihood of dying are cancer, female gender, and over-aging. Patients died at their home (47.3%), in an intermediate care hospital (37.2%), or in an acute care hospital (15.5%), depending on certain explanatory factors. CONCLUSIONS: The prevalence and characteristics of advanced community-based disease coincide with that reported in the literature. Potentially, Primary Care is the reference level of care for these patients, especially if it incorporates nursing homes as a usual field of practice.


Assuntos
Doença Crônica/epidemiologia , Cuidados Paliativos , Atenção Primária à Saúde , Adulto , Idoso , Idoso de 80 Anos ou mais , Doença Crônica/terapia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Avaliação das Necessidades , Prevalência , Estudos Prospectivos , Índice de Gravidade de Doença , Espanha/epidemiologia , Análise de Sobrevida
18.
Part Fibre Toxicol ; 15(1): 33, 2018 08 07.
Artigo em Inglês | MEDLINE | ID: mdl-30086772

RESUMO

BACKGROUND: The biological effects of nanoparticles depend on several characteristics such as size and shape that must be taken into account in any type of assessment. The increased use of titanium dioxide nanoparticles (TiO2NPs) for industrial applications, and specifically as a food additive, demands a deep assessment of their potential risk for humans, including their abilities to cross biological barriers. METHODS: We have investigated the interaction of three differently shaped TiO2NPs (nanospheres, nanorods and nanowires) in an in vitro model of the intestinal barrier, where the coculture of Caco-2/HT29 cells confers inherent intestinal epithelium characteristics to the model (i.e. mucus secretion, brush border, tight junctions, etc.). RESULTS: Adverse effects in the intestinal epithelium were detected by studying the barrier's integrity (TEER), permeability (LY) and changes in the gene expression of selected specific markers. Using Laser Scanning Confocal Microscopy, we detected a different behaviour in the bio-adhesion and biodistribution of each of the TiO2NPs. Moreover, we were able to specifically localize each type of TiO2NPs inside the cells. Interestingly, general DNA damage, but not oxidative DNA damage effects, were detected by using the FPG version of the comet assay. CONCLUSIONS: Results indicate different interactions and cellular responses related to differently shaped TiO2NPs, nanowires showing the most harmful effects.


Assuntos
Absorção Intestinal/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Nanosferas/toxicidade , Nanotubos/toxicidade , Nanofios/toxicidade , Titânio/toxicidade , Células CACO-2 , Células HT29 , Humanos , Mucosa Intestinal/metabolismo , Nanosferas/química , Nanotubos/química , Nanofios/química , Tamanho da Partícula , Permeabilidade , Propriedades de Superfície , Titânio/química , Titânio/farmacocinética
19.
J Palliat Care ; 33(4): 247-251, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-30001656

RESUMO

Palliative care must be early applied to all types of advanced chronic and life limited prognosis patients, present in all health and social services. Patients' early identification and registry allows introducing palliative care gradually concomitant with other measures. Patients undergo a systematic and integrated care process, meant to improve their life quality, which includes multidimensional assessment of their needs, recognition of their values and preferences for advance care planning purposes, treatments review, family care, and case management. Leaded by the National Department of Health, a program for the early identification of these patients has been implemented in Catalonia (Spain). Although the overall benefits expected, the program has raised some ethical issues. In order to address these challenges, diverse institutions, including bioethics and ethics committees, have elaborated a proposal for the program's advantages. This paper describes the process of evaluation, elaboration of recommendations, and actions done in Catalonia.


Assuntos
Planejamento Antecipado de Cuidados/ética , Planejamento Antecipado de Cuidados/organização & administração , Doença Crônica/terapia , Enfermagem de Cuidados Paliativos na Terminalidade da Vida/ética , Enfermagem de Cuidados Paliativos na Terminalidade da Vida/organização & administração , Cuidados Paliativos/ética , Cuidados Paliativos/organização & administração , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Encaminhamento e Consulta , Espanha , Inquéritos e Questionários
20.
J Appl Toxicol ; 38(9): 1195-1205, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-29722448

RESUMO

The widespread use of titanium dioxide nanoparticles (TiO2 NPs) in commercial food products makes intestinal cells a suitable target. Accordingly, we have used the human colon adenocarcinoma Caco-2 cells to detect their potential harmful effects. Caco-2 cells can differentiate in to enterocytic-like cells, forming consistent cell monolayers and are used as a model of the intestinal barrier. Using both undifferentiated and differentiated Caco-2 cells, we have explored a set of biomarkers, aiming to evaluate undesirable effects associated to TiO2 NP exposure. Results indicate non-toxic effects in exposures ranging 1-200 µg ml-1 . Significant differences were observed in cell uptake, with a higher amount of incorporated TiO2 NPs in undifferentiated cells, as visualized using confocal microscopy. In well-established monolayers, translocation was detected using both confocal microscopy and transmission electron microscopy with energy-dispersive X-ray spectroscopy. In spite of the observed uptake and translocation, TiO2 NP exposures did not modify the integrity of the monolayer, as measured using the transepithelial electrical resistance and Lucifer yellow methods. The potential genotoxic effects in differentiated cells were evaluated in the comet assay, with and without formamidopyrimidine DNA glycosylase enzyme to detect oxidatively the damaged DNA bases. Although some changes were detected at the lower dose (10 µg ml-1 ), no effects were observed at higher doses.


Assuntos
Absorção Intestinal , Mucosa Intestinal/metabolismo , Nanopartículas Metálicas , Titânio/metabolismo , Transporte Biológico , Células CACO-2 , Diferenciação Celular , Dano ao DNA , Relação Dose-Resposta a Droga , Impedância Elétrica , Humanos , Absorção Intestinal/efeitos dos fármacos , Mucosa Intestinal/efeitos dos fármacos , Mucosa Intestinal/ultraestrutura , Nanopartículas Metálicas/toxicidade , Estresse Oxidativo , Permeabilidade , Medição de Risco , Titânio/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA